Searchable abstracts of presentations at key conferences in endocrinology

ea0004p87 | Steroids | SFE2002

CONCORDANCE OF RESULTS FOR TWO METHODS OF CALCULATING FREE TESTOSTERONE CONCENTRATION. ARE THE RESULTS VALID?

Ivison F , Robinson A , Diver M

Many laboratories offer a simple ratio of total testosterone (T):SHBG as an index (FAI) of free androgens. Methods for measuring free T (fT) are time consuming (equilibrium dialysis, ED) or reveal concentrations at odds with accepted values (RIA). The validity of FAI has been questioned and an alternative assessment by computation of fT recommended (1). We use a simpler calculation (2) producing results comparable to established literature. We have compared results obtained by...

ea0010p3 | Clinical case reports/Governance | SFE2005

Scleromyxedema, a cause for primary hypogonadism?

Joshi A , Joseph F , Diver M , Vora J

A 60 year old pest control worker presented to the dermatologists with a 3-month history of progressive thickening and change in texture of skin lesions affecting the face, lips and eyelids. Histology revealed papular mucinosis/lichen myxoedematosus and he was treated with plasma exchange, high dose steroids and cyclophosphamide. Investigations for associated tiredness, four months following presentation and initiation of therapy revealed impaired GH and cortisol responses to ...

ea0007p288 | Clinical case reports | BES2004

Testosterone-replacement stimulated hyperprolactinaemia

Sodi R , Fikri R , Diver M , Ranganath L , Vora J

TESTOSTERONE-REPLACEMENT STIMULATED HYPERPROLACTINAEMIAR Sodi, R Fikri, M Diver, L Ranganath & J Vora*.Departments of Clinical Chemistry and Endocrinology*Royal Liverpool and Broadgreen University Hospital,Liverpool, UK. L7 8XP.Around half of all men with macroprolactinomas have hypogonadism and may require exogenous testosterone replacement. However, testoste...

ea0005p200 | Reproduction | BES2003

Biological variation of free androgen index and bioavailable testosterone in PCOS: Implications for estimation of hyperandrogenaemia

Jayagopal V , Diver M , Kilpatrick E , Jennings P , Atkin S

Objective: Bioavailable testosterone (BioT) is measured directly by bioassay or estimated by calculating the free androgen index (FAI) and reflects hyperandrogenaemia more accurately than measurement of total testosterone in plasma. A comparison of the biological variation of FAI and measured BioT was undertaken to determine the relative suitability of these estimates in PCOS.Method: The biological variation of BioT and FAI was assessed in 12 PCOS patients (median age 28yr...

ea0038p402 | Steroids | SFEBES2015

Bioinformatic analysis of microRNAs associated with aldosterone secretion

Ab Razak Nur Izah , MacKenzie Scott M , Diver Louise A , McBride Martin M , Davies Eleanor

Many cases of hypertension are associated with inappropriately high levels of aldosterone secretion and it has been proposed that microRNAs play a role in this dysregulation. Previously, we showed that microRNAs expressed within the adrenal cortex significantly repress aldosterone production. Furthermore, stimulation of aldosterone secretion by three different means in the H295R cell line – the most commonly-used in vitro model of the human adrenal cortex – ...

ea0005p152 | Endocrine Tumours and Neoplasia | BES2003

Can petrosal sinus ACTH and prolactin responses to CRH help localize the tumour in Cushing's disease due to pituitary microadenomas?

Daousi C , Nixon T , Hayden C , Foy P , Diver M , MacFarlane I

Aims: The majority of patients with Cushing's disease have pituitary microadenomas and preoperative localization can be helpful during transphenoidal surgery. Inferior petrosal sinus sampling (IPSS) of ACTH and responses to CRH may show higher levels on the side ipsilateral to the tumour, although this remains controversial. A few small studies suggested a prolactin response to CRH during IPSS. We assessed whether prolactin responses to CRH can help lateralize the microadenoma...